Skip to main content
OpenTrials

Clinical trial condition

Colonic Diseases

Explore clinical trials studying Colonic Diseases. Study availability and eligibility vary by location and protocol.

7,489 public trials 1,474 recruiting studies
Refine in advanced search Browse all conditions

Colonic Diseases trial results

Recruiting

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

NCT06720987

Conditions
CRC (Colorectal Cancer), Colonic Diseases, Colorectal Neoplasms, +12 more
Locations
  • Mayo Clinic, Phoenix Phoenix, Arizona, United States
  • Sarah Cannon Cancer Institute at HealthONE Denver, Colorado, United States
  • Mayo Clinic, Jacksonville Jacksonville, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

NCT06975722

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Investigational Site Number: 8400009 Escondido, California, United States
  • Investigational Site Number: 8400006 Lancaster, California, United States
  • Investigational Site Number: 8400025 Thousand Oaks, California, United States
  • Investigational Site Number: 8400024 Jacksonville, Florida, United States
View all 67 locations
View Trial Details
Recruiting

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

NCT07020221

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 14 locations
View Trial Details
Recruiting

A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI

NCT07543744

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • State Budgetary Healthcare Institution of the Arkhangelsk Region "Arkhangelsk Oncology Dispensary" Arkhangelsk, Russia
  • Moscow City Oncology Hospital No. 62 (MGOB 62) Istra, Russia
  • Regional Budgetary Healthcare Institution "Ivanovo Regional Oncology Dispensary" Ivanovo, Russia
  • State Budgetary Healthcare Institution of Kaluga Region "Kaluga Regional Clinical Oncology Dispensary" Kaluga, Russia
View all 26 locations
View Trial Details

Related conditions